These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21478328)

  • 101. A change point-based analysis procedure for improving the success rate of decision-making in clinical trials with delayed treatment effects.
    Xie LS; Lu H
    Front Pharmacol; 2023; 14():1186456. PubMed ID: 37767405
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Defining information fractions in group sequential clinical trials with multiple endpoints.
    Xu T; Qin Q; Wang X
    Contemp Clin Trials Commun; 2018 Jun; 10():77-79. PubMed ID: 29696161
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Some Distributions and Their Implications for an Internal Pilot Study With a Univariate Linear Model.
    Coffey CS; Muller KE
    Commun Stat Theory Methods; 2000 Jan; 29(12):. PubMed ID: 24307749
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Defensive efficacy interim design: Dynamic benefit/risk ratio view using probability of success.
    Tang Z
    J Biopharm Stat; 2017; 27(4):683-690. PubMed ID: 27295497
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Sample size estimation in clinical trial.
    Sakpal TV
    Perspect Clin Res; 2010 Apr; 1(2):67-9. PubMed ID: 21829786
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Sequential Estimation of p with Squared Relative Error Loss.
    Cabilio P; Robbins H
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):191-3. PubMed ID: 16592210
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Interim analysis: A rational approach of decision making in clinical trial.
    Kumar A; Chakraborty BS
    J Adv Pharm Technol Res; 2016; 7(4):118-122. PubMed ID: 27833889
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Chronic kidney disease: Skin sodium linked to left ventricular hypertrophy.
    Carney EF
    Nat Rev Nephrol; 2017 Apr; 13(4):194. PubMed ID: 28239175
    [No Abstract]   [Full Text] [Related]  

  • 109. Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
    Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
    Clin Exp Nephrol; 2017 Dec; 21(6):1146. PubMed ID: 28889397
    [No Abstract]   [Full Text] [Related]  

  • 110. Left ventricular function and chronic kidney disease: how soon does it start?
    Campese VM
    Nephrol Dial Transplant; 2014 Nov; 29(11):1989-91. PubMed ID: 25209365
    [No Abstract]   [Full Text] [Related]  

  • 111. Studies Making Use of the Same Randomized Clinical Trial Cohorts.
    Jiang M; Lin Y; Su S
    JAMA Intern Med; 2019 Oct; 179(10):1446-1447. PubMed ID: 31589263
    [No Abstract]   [Full Text] [Related]  

  • 112. Studies Making Use of the Same Randomized Clinical Trial Cohorts-Reply.
    Smyth B
    JAMA Intern Med; 2019 Oct; 179(10):1447. PubMed ID: 31589269
    [No Abstract]   [Full Text] [Related]  

  • 113. Sample Size Estimation: Often A Disregarded, And Yet An Essential Driver Of Research Quality And Integrity.
    Al-Qahtani AA; S Alenzi AA; Ali AS
    J Ayub Med Coll Abbottabad; 2020; 32(3):424-425. PubMed ID: 32829567
    [No Abstract]   [Full Text] [Related]  

  • 114. Sample size estimation.
    Chander NG
    J Indian Prosthodont Soc; 2017; 17(3):217-218. PubMed ID: 28936033
    [No Abstract]   [Full Text] [Related]  

  • 115. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial.
    Thadhani R; Appelbaum E; Pritchett Y; Chang Y; Wenger J; Tamez H; Bhan I; Agarwal R; Zoccali C; Wanner C; Lloyd-Jones D; Cannata J; Thompson BT; Andress D; Zhang W; Packham D; Singh B; Zehnder D; Shah A; Pachika A; Manning WJ; Solomon SD
    JAMA; 2012 Feb; 307(7):674-84. PubMed ID: 22337679
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival.
    Hade EM; Young GS; Love RR
    Trials; 2019 Aug; 20(1):527. PubMed ID: 31443726
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Parathyroid ultrasonography and bone metabolic profile of patients on dialysis with hyperparathyroidism.
    Ribeiro C; Penido MG; Guimarães MM; Tavares Mde S; Souza Bd; Leite AF; de Deus LM; Machado LJ
    World J Nephrol; 2016 Sep; 5(5):437-47. PubMed ID: 27648407
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Adaptive designs undertaken in clinical research: a review of registered clinical trials.
    Hatfield I; Allison A; Flight L; Julious SA; Dimairo M
    Trials; 2016 Mar; 17(1):150. PubMed ID: 26993469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.